16h agoThe FlyBULLISH 58General
Archived explainer. For the current picture see today's LFST page.
Why Is LIFESTANCE HEALTH GR (LFST) Stock Up Today?
By the Top Tier Newswire AI Desk · August 11, 2026 at 12:16 AM ET · reviewed against 2 wire stories
LIFESTANCE HEALTH GR (LFST) is up +9.78% in the latest session. Our newswire has captured 2 stories on LFST across 2 sources in the last 36 hours, with AI sentiment reading bullish (avg 63/100).
Public view, delayed 4h. Every headline, price and sentiment read below — and this write-up itself — reaches Pro subscribers live. Public readers see it once it clears the delay.
LifeStance Health Group (LFST) rose 9.78% to $11.90 in morning trading on Monday. The move followed a recent upgrade from Hedgeye, which added the stock as a new long idea. Analysts cited the firm's recent Q2 results and raised FY2026 sales guidance as key drivers of the rally.
What Happened
The stock climbed on the back of a bullish call from Hedgeye, which cited a potential 32, 60% upside based on revenue and EBITDA forecasts. The firm highlighted LifeStance’s Q2 earnings beat and the recent upward revision of its full-year 2026 sales guidance. The guidance now ranges from $1.685 billion to $1.725 billion, exceeding the $1.665 billion estimate. Q2 results also showed earnings of $0.06 per share, surpassing the $0.04 estimate, while revenue hit $435.354 million, beating the $414.577 million forecast.
BTIG also raised its price target for LifeStance to $16 from $15, maintaining a Buy rating. The stock is currently trading near its 52-week high of $11.76, with a market cap of $4.1 billion. Recent insider activity has seen several sales, with total insider sales over the past 90 days reaching $289.8 million.
What The Data Shows
The stock has shown strong momentum, trading near its 52-week high. Intraday volume has been elevated, though specific figures are not provided. The company’s revenue has grown 20.4% in the trailing twelve months, but its net margin remains at 3.2%, and its P/E ratio is elevated at 84.1. The stock’s beta of 1.20 indicates higher volatility than the market. Recent Q3 sales guidance of $420 million to $440 million also suggests continued confidence in the company’s performance.
What To Watch
LifeStance has not scheduled earnings in the near term. Traders should monitor the breadth of analyst coverage and any further revisions to guidance as key indicators of momentum.
AI-assisted analysis composed exclusively from headlines and data on the Top Tier newswire. Public view is delayed 4 hours from real time. Not financial advice.
LFST by the numbers
Last: $11.90Session: +9.78%Coverage: 2 stories / 2 sourcesAI sentiment: 63/100 (bullish)Mkt cap: $4.1BP/E: 84.152w: $3.81 to $11.76
The headlines behind the move
17h agoSeeking AlphaBULLISH 67Analyst
LifeStance Health gains as Hedgeye adds as new long idea
LifeStance Health (LFST) jumps on Hedgeye long call: 32–60% upside backed by revenue/EBITDA forecasts, Q2 beat and FY26 raise—read the thesis.
Want the next move before the crowd? The live terminal streams every headline in real time with watchlist alerts, AI sentiment, and the full data stack behind this page.Get Pro Access →
More on LFST: full news and sentiment history. Sentiment scores are AI-derived research signals, not financial advice.
Earlier LFST move explainers: 2026-08-11 · 2026-08-10